project id: TCGA-KIRP; case submitter id: TCGA-UZ-A9PM; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.66; rna integrity number: 8.4; age at index: 62; days to birth: -22646; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; age at diagnosis: 22646; ajcc clinical m: M0; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to last follow up: 3811.0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 480.0; portion submitter id: TCGA-UZ-A9PM-01A-21; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 15.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 85.0; percent tumor nuclei: 75.0;